News
HEPAFAT-SCAN® FATTY LIVER STUDY COMMENCES IN THE USA
We are excited to announce that the paediatric fatty liver disease study using HepaFat-Scan has now commenced in the USA. It is being run in collaboration with the prestigious children’s hospital,
Entrepreneur of the Year Award – Western Region Technology Winner!
Congratulations to our Chief Scientific Officer, Professor Tim St Pierre, for winning the Technology category of the Western Region EY Entrepreneur of the Year™ award on behalf of Resonance Health!
Conference Update: China Symposium on NAFLD in Shanghai
The symposia on Non-alcoholic Fatty Liver Disease (NAFLD) in Shanghai was co-organised by the China Medical Association and Zhongshan Hospital Fudan University, chaired by Prof Gao Xin.
Conference Update: Showcasing Resonance Health in Europe
Resonance Health attended or exhibited at three conferences in Europe in June 2015. We profiled both our FerriScan® and HepaFat-Scan® technologies to thousands of delegates and generated almost a hundred
Resonance Health News June 2015
Welcome to our June 2015 newsletter. In this issue we have some latest news from the clinical community, details of exciting developments in our R&D department and some new Resonance Health faces
LIC-NET Italy Advances Best Practice in Iron Monitoring
Headed by Professor Aurelio Maggio (Director of the Department of Haematology and Oncology at Villa Sofia-Cervello Hospital, Palermo, Italy) the Liver Iron Cutino Network (LIC-NET) is a growing network of